Prosensa Technologies B.V.
Recorded under 4 name spellings.
Recorded as renamed to Biomarin Technologies B.V. (2015)
When these terms end
Fee deadlines
No maintenance fee falls due on this company's record before Nov 20, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
No patent on this record is in force and held under this name now.
Sources and methods
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 abandoned · 6 no status recorded
Showing 1 to 10 of 11, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 14/678,517 | Apr 3, 2015 | No status recorded | |
| 14/581,633 | Dec 23, 2014 | No status recorded | |
| 14/444,244 | Jul 28, 2014 | No status recorded | |
| 14/200,251 | METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA | Mar 7, 2014 | Abandoned |
| 14/134,971 | METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA | Dec 19, 2013 | Abandoned |
| 14/097,210 | METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNA | Dec 4, 2013 | Abandoned |
| 14/056,464 | Oct 17, 2013 | No status recorded | |
| 13/094,571 | Methods and Means for Efficient Skipping of Exon 52 of the Human Dystrophin Gene | Apr 26, 2011 | Abandoned |
| 13/266,110 | Apr 26, 2010 | No status recorded | |
| 12/377,160 | Treatment of Genetic Disorders Associated with DNA Repeat Instability | Aug 10, 2007 | Abandoned |